Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Agilent Introduces SureSelectQXT Target Enrichment Kits
Wednesday, June 04, 2014
Solution empowers clinical research sequencing with quick workflow, minimal sample input.

OGT to Sell Cytocell Products Direct in North America
Monday, June 02, 2014
The acquisition brings immediate customer benefits.

Contract Research Organizations Adopt Ion Torrent Next-Generation Sequencing Platform
Monday, June 02, 2014
MolecularMD and Selah Genomics to Use Oncomine Cancer Research Panel for Clinical Trial Design.

Advanced Liquid Level Detection with Tecan’s Cavro® Omni Robot
Thursday, May 22, 2014
Offers ‘hybrid’ liquid sensing, provides exceptional process security and full traceability.

New 20µl Liquidator 96 from Anachem
Thursday, May 22, 2014
Maximizes users workflow with fast, 96-well pipetting and no complex programming.

N-of-One to Provide Clinical Interpretation for Guardant360™ Tests
Monday, May 19, 2014
Breakthrough blood test enables next generation sequencing of solid tumor DNA.

Eurofins Genomics to Supply Oligonucleotides and DNA Sequencing to Research Councils
Friday, May 16, 2014
UK Shared Business Services Ltd selects Eurofins Genomics as preferred supplier for oligonucleotides and DNA sequencing services.

MO BIO Laboratories Launches a New Kit for FFPE Tissue RNA Isolation
Monday, May 12, 2014
This latest kit features a very efficient protocol which includes complete lysis and extraction of total RNA from formalin-fixed, paraffin-embedded tissues without the use of toxic organic solvents.

OGT Launch Cancer Sequencing Panel at ACGS
Wednesday, April 30, 2014
Accurate solid tumour profiling for clinical and translational research

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 219
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv